2025-11-06 05:21:46
Latest Post
Avalon Technologies Ltd Q2FY26 consolidated net profit at Rs. 24.97 crores
CyberTech Systems and Software Ltd Q2 FY2025-26 consolidated profit at Rs. 8.65 crores
Piramal Pharma Ltd consolidated Q2FY26 loss at Rs. 99.22 crores
Syngene International Ltd Q2FY26 consolidated PAT declines to Rs. 67.1 crores
Magellanic Cloud Ltd Q2 FY2026 consolidated PAT at Rs. 27.61 crores
Stock Report
Krebs Biochemicals and Industries Ltd Q2 FY2026 loss at Rs. 6.14 crores
Posted On : 2025-11-04 20:01:33( TIMEZONE : IST )
Krebs Biochemicals and Industries Limited has reported Standalone financial results for the period ended September 30, 2025.
Financial Results (Q2 FY2026) - QoQ Comparison
The company has reported total income of Rs. 4.1741 crores during the period ended September 30, 2025 as compared to Rs. 5.4926 crores during the period ended June 30, 2025.
The company has posted net profit / (loss) of Rs. -6.1428 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs. -5.3243 crores for the period ended June 30, 2025.
The company has reported EPS of Rs. -2.85 for the period ended September 30, 2025 as compared to Rs. -2.47 for the period ended June 30, 2025.
| Financials | Q2 FY2026 | Q1 FY2026 | % Change |
| Total Income | ₹ 4.1741 crs | ₹5.4926 crs |  -24.01% |
| Net Profit | ₹-6.1428 crs | ₹-5.3243 crs |  15.37% |
| EPS | ₹-2.85 | ₹-2.47 | 15.38% |
Financial Results (Q2 FY2026) - YoY Comparison
The company has reported total income of Rs. 4.1741 crores during the period ended September 30, 2025 as compared to Rs.12.9414 crores during the period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.-6.1428 crores for the period ended September 30, 2025 as against net profit / (loss) of Rs.-5.7608 crores for the period ended September 30, 2024.
The company has reported EPS of Rs.-2.85 for the period ended September 30, 2025 as compared to Rs.-2.67 for the period ended September 30, 2024.
| Financials | Q2 FY2026 | Q2 FY2025 | % Change |
| Total Income | ₹ 4.1741 crs | ₹12.9414 crs | -67.75% |
| Net Profit | ₹-6.1428 crs | ₹-5.7608 crs | 6.63% |
| EPS | ₹-2.85 | ₹-2.67 | 6.74% |
Financial Results (Half Year Ended FY2026) - YoY Comparison
The company has reported total income of Rs.9.6667 crores during the 6 Months period ended September 30, 2025 as compared to Rs.25.8639 crores during the 6 Months period ended September 30, 2024.
The company has posted net profit / (loss) of Rs.-11.4671 crores for the 6 Months period ended September 30, 2025 as against net profit / (loss) of Rs.-10.9320 crores for the 6 Months period ended September 30, 2024.
The company has reported EPS of Rs.-5.32 for the 6 Months period ended September 30, 2025 as compared to Rs.-5.07 for the 6 Months period ended September 30, 2024.
| Financials | Half Year Ended FY2026 | Half Year Ended FY2025 | % Change |
| Total Income | ₹9.6667 crs | ₹25.8639 crs | -62.62% |
| Net Profit | ₹-11.4671 crs | ₹-10.9320 crs | 4.89% |
| EPS | ₹-5.32 | ₹-5.07 | 4.93% |
Shares of Krebs Biochemicals and Industries Limited was last trading in BSE at Rs. 70.79 as compared to the previous close of Rs. 69.20. The total number of shares traded during the day was 519 in over 8 trades.
The stock hit an intraday high of Rs. 70.91 and intraday low of 69.50. The net turnover during the day was Rs. 36096.00.
